Managers / Q2 2022 · view latest →
Valliance Asset Management Ltd
CIK 0001846639 · 16/F, 8 QUEEN'S ROAD, CENTRAL, K3, 000000 · 852 35657001
Summary
Valliance Asset Management Ltd reported $24M in U.S.-listed holdings across 3 positions for Q2 2022.
The portfolio is heavily concentrated: Summit Healthcre Acquistn alone accounts for 39.9% of reported value.
Compared with Q1 2022, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 72.2% · $18M
- ADR · 27.8% · $7M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NTESNETEASE INC | NEW | +72.7K | 72.7K | +$7M | $7M |
| SUMMIT HEALTHCRE ACQUISTN CO | HELD | +0 | 1.00M | −$27,000 | $10M |
| HH&L ACQUISITION CO | HELD | +0 | 800.0K | −$24,000 | $8M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SUMMIT HEALTHCRE ACQUISTN CO | UNIT 06/03/2026 | 39.91% | $10M | 1.00M |
| 2 | HH&L ACQUISITION CO | UNIT 99/99/9999 | 32.32% | $8M | 800.0K |
| 3 | NTESNETEASE INChistory → | SPONSORED ADS | 27.77% | $7M | 72.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $122M | 8 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $240M | 11 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $13M | 1 | Oct 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $13M | 5 | Jul 31, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $44M | 25 | May 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $56M | 18 | Feb 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $82M | 7 | Oct 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $66M | 15 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $41M | 8 | May 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $3M | 6 | Jan 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $27M | 14 | Oct 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $6M | 4 | Jul 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $56M | 9 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $71M | 8 | Feb 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $36M | 6 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $24M | 3 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $18M | 2 | Apr 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $41M | 3 | Jan 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $99M | 6 | Oct 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $23M | 3 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $8M | 1 | May 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $47M | 3 | Feb 18, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.